- 1. 1-(3-Furanyl)-4-hydroxy-1-pentanone
- [A natural toxic furan isolated from a fungus-infected sweet potato (Ipomoea batatas) with potential antineoplastic activity. Ipomeanol is activated by mixed function oxidases in vivo to its epoxide form, an alkylating agent that covalently binds cell macromolecules. This agent causes cell death by a p53-independent mechanism. (NCI04) ( NCI )] (UMLS (NCI) C0048420) =Organic Chemical; Biologically Active Substance
| - 51. 5-FU/TMTX
- (UMLS (NCI) C0678039) =Therapeutic or Preventive Procedure ;
|
- 2. 5-FU/FUDR
- (UMLS (NCI) C0280815) =Therapeutic or Preventive Procedure ;
| - 52. 5-FU/TXT
- (UMLS (NCI) C0677975) =Therapeutic or Preventive Procedure
|
- 3. 5-FU/G-CSF/HU/IFN-A
- (UMLS (NCI) C0338187) =Therapeutic or Preventive Procedure ;
| - 53. 5-FU/VNB
- (UMLS (NCI) C0281257) =Therapeutic or Preventive Procedure ;
|
- 4. 5-FU/G-CSF/IFN-A
- (UMLS (NCI) C0338151) =Therapeutic or Preventive Procedure
| - 54. 5-FU/VP-16
- (UMLS (NCI) C0281647) =Therapeutic or Preventive Procedure ;
|
- 5. 5-FU/GAN
- (UMLS (NCI) C0281382) =Therapeutic or Preventive Procedure ;
| - 55. 5FU/Leucovorin
- (UMLS (NCI) C0278707) =Therapeutic or Preventive Procedure
|
- 6. 5-FU/HMM/MITO
- (UMLS (NCI) C0279184) =Therapeutic or Preventive Procedure
| - 56. 5FU/Leucovorin/Gemcitabine
- (UMLS (NCI) C0677790) =Therapeutic or Preventive Procedure
|
- 7. 5-FU/HU
- (UMLS (NCI) C0280678) =Therapeutic or Preventive Procedure
| - 57. 5FU/Leucovorin/Irinotecan
- (UMLS (NCI) C0281534) =Therapeutic or Preventive Procedure
|
- 8. 5-FU/HU/IFN-A
- (UMLS (NCI) C0338175) =Therapeutic or Preventive Procedure
| - 58. 5FU/Leucovorin/Levamisole
- (UMLS (NCI) C0278901) =Therapeutic or Preventive Procedure
|
- 9. 5-FU/HU/IUDR
- (UMLS (NCI) C0280826) =Therapeutic or Preventive Procedure
| - 59. Fubrogonium Iodide
- (UMLS (NCI) C0603281) =Organic Chemical; Pharmacologic Substance
|
- 10. 5-FU/HU/TAX
- (UMLS (NCI) C0393082) =Therapeutic or Preventive Procedure
| - 60. FUCH HETROCHROM CYCLITIS
- (UMLS (ICD9CM) C0016782) =Disease or Syndrome ;
|
- 11. 5-FU/ICI D1694
- (UMLS (NCI) C0677774) =Therapeutic or Preventive Procedure
| - 61. fucose
- [methylpentose structurally derived from galactose; the L isomer occurs naturally in various oligosaccharides and polysaccharides and fucosides and in the carbohydrate portion of some mucopolysaccharides and glycoproteins, including the A, B, and O blood group antigens. ( CSP )] (UMLS (CSP) C0016786) =Carbohydrate; Biologically Active Substance =hexose;
|
- 12. 5-FU/ICRF-159/MeCCNU
- (UMLS (NCI) C0279362) =Therapeutic or Preventive Procedure
| - 62. Fudosteine
- (UMLS (NCI) C0756016) =Amino Acid, Peptide, or Protein; Pharmacologic Substance
|
- 13. 5-FU/IFN-A
- (UMLS (NCI) C0338085) =Therapeutic or Preventive Procedure
| - 63. FUG1
- [RanGAP1, is a homodimeric 65-kD polypeptide that specifically induces the GTPase activity of RAN, but not of RAS by over 1,000-fold. RanGAP1 is the immediate antagonist of RCC1, a regulator molecule that keeps RAN in the active, GTP-bound state. The RANGAP1 gene encodes a 587-amino acid polypeptide. The sequence is unrelated to that of GTPase activators for other RAS-related proteins, but is 88% identical to Fug1, the murine homolog of yeast Rna1p. RanGAP1 and RCC1 control RAN-dependent transport between the nucleus and cytoplasm. RanGAP1 is a key regulator of the RAN GTP/GDP cycle. (LocusLink) ( NCI )] (UMLS (NCI) C0294869) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 14. 5-FU/IFN-A/IL-2
- (UMLS (NCI) C0338141) =Therapeutic or Preventive Procedure
| - 64. Fuhrman Grade
- [A 4-point scale that indicates the level of protein synthesis activity in malignant cells based on the appearance of the nuclei. The grading ranges from I (best prognosis) to IV (worst prognosis). ( NCI )] (UMLS (NCI) C1300579) Fuhrman Nuclear Grade;
=Clinical Attribute |
- 15. 5-FU/IFN-A/MITO
- (UMLS (NCI) C0338093) =Therapeutic or Preventive Procedure
| - 65. fulfills
- [The source act fulfills (in whole or in part) the target act. Source act must be in a mood equal or more actual than the target act. ( HL7V3.0 )] (UMLS (HL7) C1550543) =Idea or Concept =is sequel;
=is occurrence of; schedules; references order |
- 16. 5-FU/IFN-A/PALA
- (UMLS (NCI) C0338107) =Therapeutic or Preventive Procedure ;
| - 66. Full
- [Containing as much or as many as is possible or normal. ( NCI )] (UMLS (NCI) C0443225) =Qualitative Concept
|
- 17. 5-FU/IFN-B
- (UMLS (NCI) C0279438) =Therapeutic or Preventive Procedure
| - 67. full awareness
- [Target person is fully aware of the issue. ( HL7V3.0 )] (UMLS (HL7) C1550514) =Idea or Concept =TargetAwareness;
|
- 18. 5-FU/IL-1B
- (UMLS (NCI) C0280480) =Therapeutic or Preventive Procedure ;
| - 68. Full Disclosure
- (UMLS (HL7) C1548949) =Idea or Concept =Consent Disclosure Level;
|
- 19. 5-FU/IUDR
- (UMLS (NCI) C0278672) =Therapeutic or Preventive Procedure
| - 69. Full Gospel
- (UMLS (HL7) C1699054) =Population Group =Religious Affiliation;
|
- 20. 5-FU/L-CF
- (UMLS (NCI) C0280780) =Therapeutic or Preventive Procedure
| - 70. Full results
- (UMLS (HL7) C1548201) =Idea or Concept =Query results level;
|
- 21. 5-FU/L-CF/LEV
- (UMLS (NCI) C0281741) =Therapeutic or Preventive Procedure
| - 71. Full Term
- (UMLS (HL7) C1547236) =Intellectual Product =Gestation Category Code;
|
- 22. 5-FU/L-CF/MTX
- (UMLS (NCI) C0281749) =Therapeutic or Preventive Procedure
| - 72. Full Time
- [Employed for a standard number of hours of working time, at least 50% or 20 hours per week ( NCI )] (UMLS (NCI) C0682295) =Finding =Employment Status;
|
- 23. 5-FU/L-OHP
- (UMLS (NCI) C0796511) Fluorouracil/Oxaliplatin =Therapeutic or Preventive Procedure
| - 73. FULL-MOUTH X-RAY
- [ ] (UMLS (ICD9CM) C0202777) =Diagnostic Procedure
|
- 24. 5-FU/L-PAM
- (UMLS (NCI) C0279387) =Therapeutic or Preventive Procedure
| - 74. FULL-THICK GRFT TO MOUTH
- [ ] (UMLS (ICD9CM) C0176447) =Therapeutic or Preventive Procedure
|
- 25. 5-FU/L-PAM/TMX
- (UMLS (NCI) C0279232) =Therapeutic or Preventive Procedure ;
| - 75. FULL-THICK HAND SKIN GRF
- [ ] (UMLS (ICD9CM) C0177705) =Therapeutic or Preventive Procedure
|
- 26. 5-FU/LEV
- (UMLS (NCI) C0279296) =Therapeutic or Preventive Procedure ;
| - 76. FULL-THICK SKIN GRFT NEC
- [ ] (UMLS (ICD9CM) C0177707) =Therapeutic or Preventive Procedure
|
- 27. 5-FU/LEV/MOAB 17-1A
- (UMLS (NCI) C0338293) =Therapeutic or Preventive Procedure
| - 77. FULL-THICKNES LAC EYELID
- [ ] (UMLS (ICD9CM) C0160461) =Injury or Poisoning
|
- 28. 5-FU/MeCCNU
- (UMLS (NCI) C0280524) =Therapeutic or Preventive Procedure
| - 78. Full-thickness skin loss due to burn [third degree NOS] of face, head, and neck
- [ ] (UMLS (ICD9CM) C0161066) =Injury or Poisoning
|
- 29. 5-FU/MeCCNU/SZC/VCR
- (UMLS (NCI) C0066687) =Therapeutic or Preventive Procedure ;
| - 79. Full-thickness skin loss due to burn [third degree NOS] of lower limb(s)
- [ ] (UMLS (ICD9CM) C0161288) =Injury or Poisoning
|
- 30. 5-FU/MeCCNU/VCR
- (UMLS (NCI) C0066686) =Therapeutic or Preventive Procedure ;
| - 80. Full-thickness skin loss due to burn [third degree NOS] of trunk
- [ ] (UMLS (ICD9CM) C0161123) =Injury or Poisoning
|
- 31. 5-FU/MITO
- (UMLS (NCI) C0279374) =Therapeutic or Preventive Procedure
| - 81. Full-thickness skin loss due to burn [third degree NOS] of upper limb, except wrist and hand
- [ ] (UMLS (ICD9CM) C0161174) =Injury or Poisoning
|
- 32. 5-FU/MITO/MTX
- (UMLS (NCI) C0278904) =Therapeutic or Preventive Procedure
| - 82. Full-thickness skin loss due to burn [third degree NOS] of wrist(s) and hand(s)
- [ ] (UMLS (ICD9CM) C0274134) =Injury or Poisoning
|
- 33. 5-FU/MITO/SZC
- (UMLS (NCI) C0082637) =Therapeutic or Preventive Procedure
| - 83. full-time
- [Employment in which the employee is expected to work at least a standard work week (defined by the US Bureau of Labor Statistics as 35-44 hours per week) ( HL7V3.0 )] (UMLS (HL7) C1553424) =Idea or Concept =EmployeeJobClass;
|
- 34. 5-FU/MITO/VCR
- (UMLS (NCI) C0060627) =Therapeutic or Preventive Procedure ;
| - 84. Full-time student
- (UMLS (HL7) C1546911) =Idea or Concept =Student Status;
|
- 35. 5-FU/MMPR/PALA
- (UMLS (NCI) C0278682) =Therapeutic or Preventive Procedure
| - 85. full-time student
- [Covered party to an insurance policy has coverage through full-time attendance at a recognized educational institution as defined by a particular insurance policy. ( HL7V3.0 )] (UMLS (HL7) C1552000) =Population Group =student;
|
- 36. 5-FU/MTX
- (UMLS (NCI) C0280603) =Therapeutic or Preventive Procedure
| - 86. Fullerene
- [One of three known pure forms of carbon that exhibits a spherical shape with a hollow interior. The number of carbon atoms comprising fullerenes is variable and several stable spherical carbon structures containing 70 or more atoms have been documented. ( NCI )] (UMLS (NCI) C0302934) =Chemical Viewed Structurally
|
- 37. 5-FU/MTX/PALA
- (UMLS (NCI) C0280516) =Therapeutic or Preventive Procedure ;
| - 87. Fully recovered
- (UMLS (HL7) C1546957) =Finding =Patient Outcome;
|
- 38. 5-FU/MTX/PRED/TSPA/VBL
- (UMLS (NCI) C0279275) =Therapeutic or Preventive Procedure ;
| - 88. fully specified ROI
- [A fully specified bounded Region of Interest (ROI) delineates a ROI in which only those dimensions participate that are specified by boundary criteria, whereas all other dimensions are excluded. For example a ROI to mark an episode of "ST elevation" in a subset of the EKG leads V2, V3, and V4 would include 4 boundaries, one each for time, V2, V3, and V4. ( HL7V3.0 )] (UMLS (HL7) C1555573) =Intellectual Product =ActBoundedROICode;
|
- 39. 5-FU/MTX/TMX
- (UMLS (NCI) C0279041) =Therapeutic or Preventive Procedure
| - 89. Fulvestrant/Gefitinib
- (UMLS (NCI) C1327927) =Therapeutic or Preventive Procedure; ;
|
- 40. 5-FU/MTX/TMX/TSPA
- (UMLS (NCI) C0280700) =Therapeutic or Preventive Procedure
| - 90. FUM/VAP AC RESP COND NEC
- [ ] (UMLS (ICD9CM) C0155897) =Disease or Syndrome
|
- 41. 5-FU/MTX/TSPA
- (UMLS (NCI) C0244554) =Therapeutic or Preventive Procedure
| - 91. FUM/VAPOR RESP COND NOS
- [ ] (UMLS (ICD9CM) C0041881) =Disease or Syndrome ;
|
- 42. 5-FU/MTX/VBL
- (UMLS (NCI) C0279825) =Therapeutic or Preventive Procedure
| - 92. FUM/VAPOR UP RESP INFLAM
- [ ] (UMLS (ICD9CM) C0155896) =Injury or Poisoning
|
- 43. 5-FU/MTX/VCR
- (UMLS (NCI) C0078399) =Therapeutic or Preventive Procedure
| - 93. fumarase
- [An enzyme that catalyzes the reversible hydration of fumaric acid to yield L-malic acid. It is one of the citric acid cycle enzymes. EC 4.2.1.2. ( MSH )] (UMLS (CSP) C0016799) =Amino Acid, Peptide, or Protein; Enzyme
|
- 44. 5-FU/PALA
- (UMLS (NCI) C0280504) =Therapeutic or Preventive Procedure ;
| - 94. fumarate
- [Compounds based on fumaric acid. ( MSH )] (UMLS (CSP) C0016801) =Organic Chemical ;
=Dicarboxylic Acids; =(E)-2-Butenedioic Acid; |
- 45. 5-FU/PBA
- (UMLS (NCI) C0392930) =Therapeutic or Preventive Procedure ;
| - 95. fumarate hydrogenase
- [creates a double bond between the 2 middle carbons of succinate to form fumarate. ( CSP )] (UMLS (CSP) C0038615) =Amino Acid, Peptide, or Protein; Enzyme =iron sulfur protein;
hydrocarbon oxidoreductase; respiratory enzyme; |
- 46. 5-FU/PRED/VCR
- (UMLS (NCI) C0279786) =Therapeutic or Preventive Procedure
| - 96. Fumazone
- (UMLS (NCI) C0118365) =Organic Chemical; Hazardous or Poisonous Substance
|
- 47. 5-FU/SMS 201-995 pa
- (UMLS (NCI) C0338277) =Therapeutic or Preventive Procedure ;
| - 97. Fumes from combustion of polyvinylchloride [PVC] and similar material in conflagration in private dwelling
- [ ] (UMLS (ICD9CM) C0417282) =Human-caused Phenomenon or Process
|
- 48. 5-FU/SZC
- (UMLS (NCI) C0278920) =Therapeutic or Preventive Procedure
| - 98. FUNCT DIS INTESTINE NEC
- [ ] (UMLS (ICD9CM) C0341089) =Disease or Syndrome
|
- 49. 5-FU/TAU
- (UMLS (NCI) C0281354) =Therapeutic or Preventive Procedure
| - 99. FUNCT DIS INTESTINE NOS
- (UMLS (ICD9CM) C0016807) =Disease or Syndrome ;
|
- 50. 5-FU/TAX
- (UMLS (NCI) C0678091) =Therapeutic or Preventive Procedure
| - 100. Function
- [The normal action performed by a structure or device. ( NCI )] (UMLS (NCI) C0542341) =Functional Concept ;
|